2. Academic Validation
  3. Preventive effects of traditional Chinese medicine formula Huoxiangzhengqi against lipopolysaccharide-induced inflammatory response

Preventive effects of traditional Chinese medicine formula Huoxiangzhengqi against lipopolysaccharide-induced inflammatory response

  • Phytomedicine. 2022 Jan 29;99:153968. doi: 10.1016/j.phymed.2022.153968.
Min Gao 1,  Zhen Zou 2,  Yu Qiu 3,  Golamaully Sumayyah 4,  Xuejun Jiang 5,  Junhao Su 1,  Xinhao Duan 1,  Chengzhi Chen 6,  Jingfu Qiu 7
Affiliations

Affiliations

  • 1 Department of Health Laboratory Technology, School of Public Health and Management, Chongqing Medical University, Chongqing, 400016, China.
  • 2 Institute of Life Sciences, Chongqing Medical University, Chongqing, 400016, China; Dongsheng Lung-Brain Disease Joint Lab, Chongqing Medical University, Chongqing, 400016, China.
  • 3 Department of Neurology, The Affiliated University-Town Hospital of Chongqing Medical University, Chongqing, 401331, China.
  • 4 Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
  • 5 Center of Experimental Teaching for Public Health, Experimental Teaching and Management Center, Chongqing Medical University, Chongqing, 400016, China.
  • 6 Dongsheng Lung-Brain Disease Joint Lab, Chongqing Medical University, Chongqing, 400016, China; Department of Occupational and Environmental Health, School of Public Health and Management, Chongqing Medical University, Chongqing, 400016, China. Electronic address: [email protected].
  • 7 Department of Health Laboratory Technology, School of Public Health and Management, Chongqing Medical University, Chongqing, 400016, China. Electronic address: [email protected].
PMID: 35183933 DOI: 10.1016/j.phymed.2022.153968
Abstract

Background: Huoxiangzhengqi oral liquid (HX), a pharmaceutical product made from traditional Chinese medicine formulas, has been commonly used in household medication for gastrointestinal disorders, but the mode of action remains largely unclear.

Purpose: This study aims to investigate whether pretreatment with HX prevents lipopolysaccharide (LPS)-induced adverse effects and the potential mechanisms involved.

Methods: Seven-week-old male C57BL/6J mice were orally administered low (1.3 ml/kg) and high doses (2.6 ml/kg) of HX for 7 days, and subsequently subjected to a single dose of LPS at 6 mg/kg. Dexamethasone served as the positive control. Each group had ten Animals.

Results: The data demonstrated that either a low or high dose of HX significantly reduced the levels of inflammation induced by LPS in both small intestinal and cortical tissues. LPS profoundly decreased the richness and evenness of the microbiota and disrupted the composition of the intestinal microbial community, but pretreatment with HX did not successfully prevent dysbiosis. No significant improvements in HX against LPS were observed in intestinal local immunity or the secretion of partial gut-brain Peptides. In addition, pretreatment with HX prevented the alterations in the expression levels of proteins related to the NF-κB pathway, including phospho-p38, p38, phospho-p44/42, p44/42, p50 and p65 induced by LPS.

Conclusion: Herein, we demonstrated for the first time that the preventive effects of HX against LPS mainly occur through the inhibition of inflammation. These findings provide novel evidence that HX may serve as a new agent for the prevention of gastrointestinal inflammation-related disorders.

Keywords

Gut microbiota; Huoxiangzhengqi; Inflammation; Lipopolysaccharide.

Figures
Products